Epimed International, INC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$2.8Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
115clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $516K
2020 $422K
2021 $436K
2022 $452K
2023 $453K
2024 $507K
2025 $2,369

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Interventional Pain Medicine $2.8M
Pain Medicine $20K
Anesthesiology $1,854
Pain Medicine (Anesthesiology) $1,761
Pain Medicine (Physical Medicine & Rehabilitation) $923
Physical Medicine & Rehabilitation $569

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Gabor Racz Lubbock, TX Interventional Pain Medicine $2,746,944.28
John Nelson Oklahoma City, OK Pain Medicine $19,833.13
Miles Day Lubbock, TX Interventional Pain Medicine $8,710.44
Stanley Golovac Merritt Island, FL Interventional Pain Medicine $4,630.48
Christopher Wiley Lebanon, NH Anesthesiology $1,192.15
Kenneth Varley Birmingham, AL Interventional Pain Medicine $600.07
Eric Freeman Edison, NJ Physical Medicine & Rehabilitation $325.19
Sam Nia Worcester, MA Anesthesiology $271.76
Rahul Mishra Frisco, TX Pain Medicine (Anesthesiology) $258.85
Bradley Keneson Granbury, TX Pain Medicine (Anesthesiology) $215.38

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.